Antihypertensive drug budget impact of the angiotensin II receptor blockers (ARB) in the UK

被引：0
|
作者：
Blak, B. T.
Weir, M. R.
Simoni-Wastila, L.
Shaya, F. T.
Cooke, C. E.
Mullins, C. D.
机构：
[1] Univ Maryland, Baltimore, MD 21201 USA
[2] Pfizer Inc, Ellicott City, MD USA
来源：
VALUE IN HEALTH | 2006年 / 9卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)63637-6
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A343 / A343
页数：1
相关论文
共 50 条
  • [1] Angiotensin receptor blockers (ARB)
    不详
    [J]. SOUTHERN MEDICAL JOURNAL, 2001, 94 (11) : 1069 - 1069
  • [2] The place of Angiotensin II receptor blockers (ARB's) in the treatment of Hypertension
    不详
    [J]. SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2004, 94 (02): : 104 - 105
  • [3] Angiotensin II receptor blockers - A new class of antihypertensive drugs
    Velasquez, MT
    [J]. ARCHIVES OF FAMILY MEDICINE, 1996, 5 (06) : 351 - 356
  • [4] Evaluation of genotoxic effects of antihypertensive drugs: Angiotensin II receptor blockers
    Huerta, Iratxe
    Barasoain, Maitane
    Telez, Mercedes
    Ortiz-Lastra, Eduardo
    Gonzalez, Javier
    Longa, Mikel
    Muga, Javier
    Barrenetxea, Gorka
    Criado, Begona
    Arrieta, Isabel
    [J]. CHROMOSOME RESEARCH, 2015, 23 : S136 - S136
  • [5] Role of antihypertensive therapy with angiotensin II receptor blockers in the elderly population
    Cosentino, E. R.
    Rinaldi, E. R.
    Meletani, S. C.
    Colombo, G.
    Campomori, F.
    Santi, F.
    Spighi, A.
    Borghi, C.
    [J]. GIORNALE DI GERONTOLOGIA, 2012, 60 (01) : 36 - 39
  • [6] Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and the risk of developing rheumatoid arthritis in antihypertensive drug users
    de Jong, Hilda J. I.
    Vandebriel, Rob J.
    Saldi, Siti R. F.
    van Dijk, Liset
    van Loveren, Henk
    Tervaert, Jan Willem Cohen
    Klungel, Olaf H.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 (08) : 835 - 843
  • [7] ASSOCIATION OF LIPID PROFILE WITH ANTIHYPERTENSIVE EFFICACY OF DIFFERENT ANGIOTENSIN II RECEPTOR BLOCKERS
    Torbas, O.
    Sirenko, Y.
    Rekovets, O.
    Kushnir, S.
    [J]. ATHEROSCLEROSIS, 2019, 287 : E159 - E159
  • [8] Pharmacogenetics of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin II receptor blockers (ARB) in cardiovascular diseases
    Agostini, Livia da Cunha
    Silva, Nayara Nascimento Toledo
    Belo, Vanessa de Almeida
    Luizon, Marcelo Rizzatti
    Lima, Angelica Alves
    da Silva, Glenda Nicioli
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2024, 981
  • [9] Assessment of the genotoxic damage induced by the antihypertensive drugs Angiotensin II receptor blockers
    Huerta, Iratxe
    Barasoain, Maitane
    Telez, Mercedes
    Ortiz-Lastra, Eduardo
    Longa, Mikel
    Muga, Javier
    Barrenetxea, Gorka
    Criado, Begona
    Arrieta, Isabel
    [J]. MOLECULAR CYTOGENETICS, 2017, 10
  • [10] Issues in drug metabolism of major antihypertensive drugs: β-blockers, calcium channel antagonists and angiotensin receptor blockers
    Christian, Hoecht
    Martin Bertera, Facundo
    Alejandro Mayer, Marcos
    Alberto Taira, Carlos
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2010, 6 (02) : 199 - 211
12345